An interventional study of Probiotics in Oropharyngeal Microbiology, sponsored by Region Skane. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-10.
Sponsored by Region Skane · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx.
Healthy people seldom have pathogenic bacteria originating from the gastro-intestinal canal but those do occur among patients, both in those not so sick and patients with more severe problems.
For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral care with probiotics and this is a pilot study to explore the possibility of the same kind of positive effects in patients due for longer (more than 4 hours of anesthesia) procedures.
Randomisation
Cultures
oropharynx
tracheal secretions
Region Skane is the lead sponsor of 386 studies on the registry; 122 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will gurgle and swallow a mixture of probiotic bacteria
Dietary Supplement: Probiotics
No intervention. What has been the standard procedure so far
Patients will gurgle and swallow a mixture of probiotic bacteria
Also known as: Lactobacillus plantarum 299, Lactobacillus plantarum 299v
Differences in pathogenic bacteria in the oropharynx and lower airways
Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in conection with anaestesia and a surgical intervention
Time frame: During hospitalization, up to 4 weeks
White blood cells
WBC taken pre-op and days 1,2,3 post-op
Time frame: During hospitalization, up to 4 weeks
CRP
CRP taken pre-op and days 1,2,3 post-op
Time frame: During hospitalization, up to 4 weeks
Pneumonia
X-ray verified infiltrations in combination with expectorates
Time frame: Up till 7 days postoperatively
Length of hospital stay
Comparison of length of stay between the intervention group and the control group
Time frame: time to discharged from hospital or patients death
Plan to share: Yes — Results are intended to be published in a scientific journal
The record gives a start of Jan 2012, a primary completion of Mar 2019 and a completion of Jul 2020. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lactobacillus plantarum 299